Bushu Pharmaceuticals
Bushu Pharmaceuticals, a leading name in the pharmaceutical industry, is headquartered in Japan and operates extensively across Asia and beyond. Founded in 2005, the company has established itself as a key player in the development and manufacturing of high-quality generic and specialty pharmaceuticals. Bushu Pharmaceuticals is renowned for its innovative approach to drug formulation, focusing on areas such as oncology, cardiology, and infectious diseases. Their commitment to quality and compliance has earned them a strong market position, with notable achievements including several regulatory approvals and partnerships with global healthcare providers. With a diverse portfolio of products, Bushu Pharmaceuticals continues to push the boundaries of pharmaceutical excellence, making significant contributions to healthcare and patient outcomes worldwide.
DitchCarbon Score
How does Bushu Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bushu Pharmaceuticals's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bushu Pharmaceuticals's reported carbon emissions
Bushu Pharmaceuticals, headquartered in Japan, currently does not have available carbon emissions data for the most recent year. However, the company is committed to reducing its carbon footprint and has established near-term reduction targets, although specific numerical targets have not been disclosed. As part of its climate commitments, Bushu Pharmaceuticals has not yet pledged to achieve net-zero emissions, indicating a focus on incremental improvements rather than a long-term net-zero strategy at this time. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly under pressure to address climate change and reduce greenhouse gas emissions across all scopes. Bushu Pharmaceuticals' commitment to sustainability reflects a growing trend in the industry, where companies are recognising the importance of environmental responsibility. The absence of specific emissions data highlights an opportunity for the company to enhance transparency and accountability in its climate initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bushu Pharmaceuticals is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
